2022 - Research.com Best Female Scientist Award
Santica M. Marcovina mostly deals with Internal medicine, Endocrinology, Diabetes mellitus, Lipoprotein and Lipoprotein. The study of Internal medicine is intertwined with the study of Placebo in a number of ways. Santica M. Marcovina combines topics linked to Coronary artery disease with her work on Endocrinology.
The study incorporates disciplines such as Body mass index and Incidence in addition to Diabetes mellitus. Her Lipoprotein study incorporates themes from Cardiology, Apolipoprotein E, Pathogenesis and Apolipoprotein B. Her study in Lipoprotein is interdisciplinary in nature, drawing from both Stroke, Relative risk, Prospective cohort study and Intensive care medicine.
Her primary scientific interests are in Internal medicine, Endocrinology, Diabetes mellitus, Lipoprotein and Lipoprotein. Her research integrates issues of Placebo and Cardiology in her study of Internal medicine. As part of her studies on Endocrinology, Santica M. Marcovina often connects relevant areas like Apolipoprotein E.
The Diabetes mellitus study combines topics in areas such as Young adult and Research design. In Lipoprotein, she works on issues like Apolipoprotein B, which are connected to Chromatography, Gene isoform and Monoclonal antibody. Her studies deal with areas such as Gastroenterology, Vascular disease and PCSK9 as well as Lipoprotein.
Santica M. Marcovina mainly investigates Internal medicine, Diabetes mellitus, Type 1 diabetes, Endocrinology and Type 2 diabetes. Her work deals with themes such as Placebo and Cardiology, which intersect with Internal medicine. Her Diabetes mellitus study combines topics in areas such as Young adult and Arterial stiffness.
Her Type 1 diabetes research focuses on Disease and how it connects with Bioinformatics and Epidemiology. Many of her studies involve connections with topics such as Efflux and Endocrinology. Her Type 2 diabetes research is multidisciplinary, incorporating perspectives in Body mass index, Nephropathy, Blood pressure, Public health and Type 2 Diabetes Mellitus.
Santica M. Marcovina spends much of her time researching Internal medicine, Lipoprotein, Diabetes mellitus, Lipoprotein and Endocrinology. Her study in Glycemic, Body mass index, Cholesterol, Odds ratio and Myocardial infarction are all subfields of Internal medicine. She interconnects Cardiology, Placebo, Metabolic syndrome and Apolipoprotein B in the investigation of issues within Lipoprotein.
As a part of the same scientific family, Santica M. Marcovina mostly works in the field of Diabetes mellitus, focusing on Cohort study and, on occasion, Area under the curve and Blood pressure. Her research investigates the connection between Lipoprotein and topics such as PCSK9 that intersect with problems in Kexin and Alirocumab. Her Type 2 diabetes study deals with Type 2 Diabetes Mellitus intersecting with Insulin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
Valery T. Miller;John LaRosa;Vanessa Barnabei;Craig Kessler.
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
S Erqou;S Kaptoge;PL Perry;E Di Angelantonio.
Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012
Elizabeth J. Mayer-Davis;Jean M. Lawrence;Dana Dabelea;Jasmin Divers.
The New England Journal of Medicine (2017)
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Tomas Vaisar;Subramaniam Pennathur;Pattie S. Green;Sina A. Gharib.
Journal of Clinical Investigation (2007)
The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study
Angela D Liese;Ralph B D'Agostino;Richard F Hamman.
Incidence of diabetes in youth in the United States.
Dana Dabelea;Ronny A Bell;Ralph B D'Agostino.
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
Daniel Périard;Amalio Telenti;Philippe Sudre;Jean Jacques Cheseaux.
Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis
Kevin D. O’Brien;Dennis D. Reichenbach;Santica M. Marcovina;Johanna Kuusisto.
Arteriosclerosis, Thrombosis, and Vascular Biology (1996)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
P J Barter;C M Ballantyne;R Carmena;M Castro Cabezas.
Journal of Internal Medicine (2006)
Effect of excessive weight gain with intensive therapy of type 1 Diabetes on lipid levels and blood pressure : Results from the DCCT
Jonathan Q. Purnell;John E. Hokanson;Santica M. Marcovina;Michael W. Steffes.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: